VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $290,000 | -24.3% | 15,043 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $383,000 | -86.8% | 15,043 | -86.6% | 0.00% | -90.0% |
Q1 2022 | $2,898,000 | -16.0% | 112,659 | +36.6% | 0.01% | -16.7% |
Q4 2021 | $3,452,000 | -25.2% | 82,450 | -22.2% | 0.01% | -25.0% |
Q3 2021 | $4,615,000 | -48.0% | 106,043 | -38.7% | 0.02% | -44.8% |
Q1 2021 | $8,875,000 | +81.4% | 173,110 | -5.3% | 0.03% | +61.1% |
Q4 2020 | $4,893,000 | – | 182,712 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |